PRNewswire

The PATHWAY HER2 (4B5) test helps to identify patients with previously-treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA. There are currently very few options for BTC patients as most cases are at an advanced stage at the ti

HONG KONG, Nov. 25, 2024 /PRNewswire/ — HashKey Exchange, the largest* licensed virtual asset exchange in Hong Kong, announced the official launch of its institutional-grade integrated service, HashKey Pro, which aims to enable brokers, banks, payment institutions, and other financial entities

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: